Literature DB >> 12198265

Hair as a biomarker for exposure to tobacco smoke.

W K Al-Delaimy1.   

Abstract

This article provides an overview of the hair nicotine biomarker for assessment of exposure to tobacco smoke, with emphasis on environmental tobacco smoke (ETS). Measurement of nicotine in hair can be an informative tool for research looking at ETS and related illnesses. There are still unresolved issues in relation to this biomarker such as influence of hair treatment, hair colour, and growth rate on nicotine levels in hair, which need to be addressed in order to further refine this biomarker for exposure assessment. Nevertheless, hair nicotine promises to be a valid and reliable measure of longer term exposure that can be readily applied in epidemiological studies of exposure to tobacco smoke, and more specifically ETS, and its risk to health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198265      PMCID: PMC1759008          DOI: 10.1136/tc.11.3.176

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  58 in total

1.  Detection of drugs in human hair for clinical and forensic applications.

Authors:  P Kintz; A Tracqui; P Mangin
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

2.  Nicotine concentration in the hair of nonsmoking mothers and size of offspring.

Authors:  P Nafstad; D Fugelseth; E Qvigstad; K Zahlen; P Magnus; R Lindemann
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Hair analysis for drugs of abuse: evaluation of analytical methods, environmental issues, and development of reference materials.

Authors:  M J Welch; L T Sniegoski; C C Allgood; M Habram
Journal:  J Anal Toxicol       Date:  1993 Nov-Dec       Impact factor: 3.367

4.  Hair concentrations of nicotine and cotinine in women and their newborn infants.

Authors:  C Eliopoulos; J Klein; M K Phan; B Knie; M Greenwald; D Chitayat; G Koren
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

5.  Cocaine metabolite (benzoylecgonine) in hair and urine of drug users.

Authors:  F Martinez; T S Poet; R Pillai; J Erickson; A L Estrada; R R Watson
Journal:  J Anal Toxicol       Date:  1993 May-Jun       Impact factor: 3.367

6.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.

Authors:  N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875

Review 7.  Biological markers of intrauterine exposure to cocaine and cigarette smoking.

Authors:  G Koren; J Klein; R Forman; K Graham; M K Phan
Journal:  Dev Pharmacol Ther       Date:  1992

8.  Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis.

Authors:  N Miyazawa; T Uematsu
Journal:  Ther Drug Monit       Date:  1992-12       Impact factor: 3.681

9.  Nicotine analysis in neonates' hair for measuring gestational exposure to tobacco.

Authors:  P Kintz; I Kieffer; J Messer; P Mangin
Journal:  J Forensic Sci       Date:  1993-01       Impact factor: 1.832

10.  Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior.

Authors:  A Mizuno; T Uematsu; A Oshima; M Nakamura; M Nakashima
Journal:  Ther Drug Monit       Date:  1993-04       Impact factor: 3.681

View more
  52 in total

1.  Passive smoking in babies: the BIBE study (Brief Intervention in babies. Effectiveness).

Authors:  Guadalupe Ortega; Cristina Castellà; Carlos Martín-Cantera; Jose L Ballvé; Estela Díaz; Marc Saez; Juan Lozano; Lourdes Rofes; Concepció Morera; Antònia Barceló; Carmen Cabezas; Jose A Pascual; Raúl Pérez-Ortuño; Esteve Saltó; Araceli Valverde; Mireia Jané
Journal:  BMC Public Health       Date:  2010-12-20       Impact factor: 3.295

2.  Secondhand tobacco smoke: an occupational hazard for smoking and non-smoking bar and nightclub employees.

Authors:  Miranda R Jones; Heather Wipfli; Shahida Shahrir; Erika Avila-Tang; Jonathan M Samet; Patrick N Breysse; Ana Navas-Acien
Journal:  Tob Control       Date:  2012-01-24       Impact factor: 7.552

3.  Acceptability and Feasibility of Hair and Salivary Biomarker Collection Among Multiethnic School-Age Children.

Authors:  Eileen M Condon; Amalia Londono Tobon; Linda C Mayes; Lois S Sadler
Journal:  Matern Child Health J       Date:  2020-07

4.  Hair nicotine levels in children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Angela D Aherrera; Patrick N Breysse; Jonathan P Winickoff; Jonathan D Klein; Sharon A McGrath-Morrow
Journal:  Pediatrics       Date:  2015-02-02       Impact factor: 7.124

5.  Oxidative Stress in Youth and Adolescents With Elevated Body Mass Index Exposed to Secondhand Smoke.

Authors:  Judith A Groner; Hong Huang; Nicholas Eastman; Luke Lewis; Mandar S Joshi; Brandon L Schanbacher; Lisa Nicholson; John A Bauer
Journal:  Nicotine Tob Res       Date:  2016-02-22       Impact factor: 4.244

6.  Toenail nicotine level as a novel biomarker for lung cancer risk.

Authors:  Wael K Al-Delaimy; Walter C Willett
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

7.  Annual average ambient particulate matter exposure estimates, measured home particulate matter, and hair nicotine are associated with respiratory outcomes in adults with asthma.

Authors:  John R Balmes; Miriam Cisternas; Patricia J Quinlan; Laura Trupin; Fred W Lurmann; Patricia P Katz; Paul D Blanc
Journal:  Environ Res       Date:  2014-01-11       Impact factor: 6.498

8.  Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers.

Authors:  Adrian A Franke; Xingnan Li; Jennifer F Lai
Journal:  Drug Test Anal       Date:  2015-12-01       Impact factor: 3.345

Review 9.  Quantification of ETS exposure in hospitality workers who have never smoked.

Authors:  Stefanie Kolb; Ulrike Brückner; Dennis Nowak; Katja Radon
Journal:  Environ Health       Date:  2010-08-12       Impact factor: 5.984

10.  Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study.

Authors:  Marcela Fu; Esteve Fernandez; Jose M Martínez-Sánchez; José A Pascual; Anna Schiaffino; Antoni Agudo; Carles Ariza; Josep M Borràs; Jonathan M Samet
Journal:  BMC Public Health       Date:  2009-09-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.